About Cryo-Cell
Investor Relations
A healthy investment in healthier futures.
Cryo-Cell has been a publicly traded company since 1991. Governed by the Securities & Exchange Commission, our common stock trades under the OTC Bulletin Board symbol CCEL. We specialize in U-Cord® stem cell preservation for family use.
Press Releases
9/3/2008
Cryo-Cell International, Inc. to Present at Wall Street Analyst Forum
9/3/2008
Cryo-Cell Presents at Wall Street Analyst Forum – September 9
8/21/2008
Cryo-Cell International and EndGenitor Technologies Announce Research Collaboration
7/10/2008
7/10/2008
Cryo-Cell Second Quarter 2008 Results - Conference Call
7/10/2008
Cryo-Cell International, Inc. Reports Second Quarter 2008 Results
6/10/2008
Cryo-Cell International, Inc. to Report Second Quarter 2008 Results
4/14/2008
Data in Cell Transplantation Demonstrates Capacity of Menstrual Stem Cells: publications
4/14/2008
Stem Cells From Menstrual Blood Show Therapeutic Potiential
4/10/2008
Cryo-Cell International, Inc. Reports First Quarter 2008 Results
3/27/2008
3/12/2008
Form 8-K - Stockholders Proposals for Annual Meeting
3/10/2008
Read more articles in the Archive
Financial Highlights
Section 16 Filings: All Insiders
Annual Reports
Quarterly & Other Reports
Stock Quote
Fundamentals
News
Chart
Real-Time Filings
Featured in
Upromise.com: helping you save for your children’s education through family blood banking (only with Cryo-cell).
Partners
Wake Forest University | Duke University | Stanford University | University of South Florida | American College of Obstetricians & Gynecologists | American College of Nurses & Midwives | Florida Blood Services | National Hispanic Medical Association | Google | Yahoo | Cryo-Cell Latin America & Asia | Babyzone.com
As seen on
Copyright © 2008 Cryo-Cell International, Inc. All Rights Reserved. Privacy Policy | Site Map
Web Design & Digital Marketing Solutions provided by Horizon Marketing Group, Inc.